Peptides can function, as antibiotics, modulators of signaling pathways, inhibitors of protein-protein interactions, as well as smaller, synthetic analogs of biologics; in aggregate, they promise to enable new opportunities for therapeutic intervention.
Join our webinar to review:
• Comparison of existing strategies for peptide hit discovery with next-generation approaches and some of the ingenious techniques for producing, displaying, encoding and screening libraries to identify high-affinity binders with strong functional activity.
• Application of concomitant advances in the generation and incorporation of non-natural building blocks and PEGylation, as well as the introduction of constrained secondary structure elements, such as a macrocyclisation
• Advanced synthesis and SAR development techniques
• How novel formulation strategies and techniques at the GMP stage are surmounting legacy barriers to delivery of peptides
